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ABSTRACT
 
Background
 
Stenotrophomonas maltophilia
 
 (SM) has been considered a nosocomial pathogen. Neverthe-
less, community acquired infection may occur more frequently than usually recognized.
 
Case
 
We describe distal necrosis of the fingers by SM in a farmer, contracted in the community and suc-
cessfully treated with a combination of cotrimoxazole and ciprofloxacin. The patient was diagnosed with
chronic lymphocytic leukaemia 6 months later.
 
Conclusions
 
This unusual presentation shows that infection with SM should be included in the differential
diagnosis of the skin and soft tissue infection, even in apparently healthy patients.
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Introduction
 
Stenotrophomonas maltophilia
 
 (SM) is a Gram-negative
bacillus, formerly known as 
 
Pseudomonas
 
 or 
 
Xanthomonas
maltophilia
 
.
 
1
 
 It is implicated as an opportunistic pathogen in
hospitalized, neutropenic patients or those on broad-spectrum
antibiotics.
 
2,3
 
 Rare cases of cutaneous infections in farmers have
been reported, as it is a microorganism isolated from soil and
agricultural plants.
 
4
 
To our knowledge, this is one of the first cases to describe
distal necrosis of the fingers due to community acquired SM
infection by an apparently healthy patient.
 
Case report
 
A 78-year-old Caucasian male farmer, living in a rural area,
with a cigarette consumption of 40/day and an alcohol intake
of about 130 g/day. His past medical history was unrevealing.
He sought medical assistance due to incapacitating pain and
progressive distal necrosis of the fourth and fifth fingers for
18 months. There was no history of Raynaud’s syndrome. The
patient had been treated with several antibiotics, with doubtful
compliance, and without success.
On examination, there were erythematous and erosive
lesions of the fingers and adherent black crusts on the distal
extremities of the fourth and fifth fingers, which were removed
with difficulty, leaving ulcers filled with a purulent exudate
(figs 1 and 2). The remainder of the physical examination,
together with a specialist cardiac and vascular evaluation, did
not show any significant abnormalities. Laboratory examina-
tion showed a macrocytic anaemia due to folic acid deficiency
(Hb, 11 g/dl; folate, 3 mg/ml; B
 
12
 
, 656 pg/ml), and a white cell
count of 11 000 leucocytes/mL (27% neutrophils, 63% lympho-
cytes). Liver and renal function tests, HIV serology, immuno-
logical screen (autoantibodies, cryoglobulins, antiphospholipid
and anticardiolipid antibodies) were within normal range.
Chest X-ray was normal and X-ray of the hands ruled out
osteomyelitis. Histopathology showed epithelial hyperplasia and
a dense homogeneous collagenization on the upper dermis. A
fig. 1 Necrosis of fifth finger extremity.
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culture of the purulent exudate, in blood, chocolate and
MacConkey agar, grew an abundant monoculture, identified by
Vitek and API20NE as SM. The isolates were sensitive to cotri-
moxazole [trimethoprim/sulphamethoxazole (TM/SMZ) ] and
doxycycline, with intermediate susceptibility to ciprofloxacin.
Antibiotic therapy, with oral TM/SMZ 160/800 mg twice
daily, for 4 weeks, resulted in progressive improvement of the
lesions. On recommencing farm work without gloves, there
was a clinical deterioration. A combination of oral TM/SMZ
160/800 mg and ciprofloxacin 750 mg, twice daily was then
instituted. There was clinical improvement despite the discon-
tinuance by the patient after 2 weeks (fig. 3). Six months later,
the patient was diagnosed with stage A chronic lymphocytic
leukaemia, with a persistent mild lymphocytosis in peripheral
blood.
 
Comments
 
SM is a Gram-negative bacillus, the sole member of the
 
Stenotrophomonas
 
 genus. Its routes of acquisition are not
completely known. It has been isolated from several
environments where it occupies ecological niches, such as
water, soil, and especially grasses, wheat and other cereals.
 
1,4
 
 It
is also detected in food sources, including frozen fish, milk and
eggs. In hospitals, it has been isolated from blood-sampling
tubes, sphygmomanometers, disinfectant solutions, oxygen
humidifier water reservoirs, dialysis machines and hands of
health-care personnel.
 
1
 
It is an important opportunistic nosocomial pathogen, asso-
ciated with a significant mortality rate, especially in patients
who are neutropenic, debilitated, immunocompromised, or on
broad-spectrum antibiotics.
 
2,3,5
 
 There are references suggesting
the existence of an altered microenvironment in neoplastic
tissue favourable for the multiplication of SM. Consequently, in
the presence of SM infection, malignancy should be ruled out.
 
6
 
SM is responsible for a wide spectrum of clinical manifesta-
tions, namely endocarditis, respiratory, urinary, gastrointestinal
infections and bacteraemia, frequently without a known portal
of entry.
The most frequently described skin and soft tissue manifes-
tations due to SM infection are subcutaneous nodules
 
2,7,8
 
 and
primary or metastatic cellulitis, which may manifest as ecthyma
gangrenosum.
 
1,5
 
 The latter is probably connected to the pro-
duction of protease and elastase enzymes by the bacteria
 
9
 
 and
seen in malignant disease, especially in haematological patients.
SM is frequently isolated from surgical wounds (e.g. tracheos-
tomies, vascular catheter sites) or traumatic wounds such as
injuries caused by corn-harvesting machines.
 
4
 
 Other manifesta-
tions include umbilical cellulitis,
 
10
 
 prepatellar bursitis
 
11
 
 infections
of burn wounds,
 
12
 
 cat scratches and human bite wounds.
Treatment in these situations is complicated by the emer-
gence of mutations and resistant strains to numerous broad-
spectrum antibiotics.
 
1,3,13,14
 
 Moreover, 
 
in vitro
 
 susceptibility
data frequently do not correlate with a successful clinical out-
come.
 
1
 
 Cotrimoxazole with or without ticarcillin-clavulanate is
the current treatment of choice.
 
2
 
 Other agents considered in
documented studies are minocycline, doxycycline and quino-
lones. New generation quinolones (trovafloxacin, clinafloxacin,
moxifloxacin, sparfloxacin) have an enhanced 
 
in vitro
 
 activity
against SM and could become an alternative if clinical studies
confirm these results.
 
15
 
 Some authors refer to the synergistic
effect of a combination of antimicrobial agents.
 
1,16
 
Despite the fact that SM has been considered to be a nosoco-
mially acquired pathogen, community acquired infection with
this bacterium may occur more frequently than previously
recognized.
 
1
 
 The present case is an example: an elderly patient
in a rural setting, in contact with products that are the natural
habitat of the pathogen and with no evidence of the usual asso-
ciated risk factors. Some degree of immune deficiency due to
his heavy alcoholic and smoking habits may be postulated.
 
17
 
Subsequently, a chronic lymphocytic leukaemia was diagnosed –
reinforcing the opinion, that with the presence of SM infection
in the absence of predisposing factors, an associated malignancy
should be ruled out. On the other hand, this case is even more
unusual because of the clinical presentation and excellent ther-
apeutic result.
fig. 2 Purulent exudate after removing the nail of the fourth finger.
fig. 3 Resolution resulted in fourth nail dystrophy and anonychia of the fifth.
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